Omalizumab (Xolair) in children with seasonal allergic rhinitis: Leukotriene release as a potential in vitro parameter to monitor therapeutic effects
Matthias Volkmar Kopp, Stefan Stenglein, Wolfgang Kamin, Frank Friedrichs, Andrea Von Berg, Stefan Zielen, Eckard Hamelmann, Ulrich Wahn, Joachim KuehrVolume:
18
Year:
2007
Language:
english
Pages:
5
DOI:
10.1111/j.1399-3038.2007.00557.x
File:
PDF, 519 KB
english, 2007